Shineco Meets Nasdaq Listing Requirements

BEIJING, June 27, 2024 — Shineco Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer of innovative diagnostic medical products and related medical devices, announced today that it has regained compliance with the minimum bid price requirement set by Nasdaq. The company received a notice from Nasdaq on June 5, 2024, confirming that its common stock closing bid price had met or exceeded $1.00 per share for 10 consecutive business days, from May 20, 2024 through June 4, 2024. This satisfies the requirements of Nasdaq Listing Rule 5550(a)(2).

About Shineco, Inc.

Shineco Inc. (“Shineco” or the “Company”) is committed to providing safe, efficient, and high-quality health and medical products and services. Through its subsidiaries, Shineco has developed 33 in-vitro diagnostic reagents and related medical devices. The company also produces and sells healthy and nutritious foods. For more information about Shineco, please visit .

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934. These statements can be identified by words like “may”, “will”, “should”, “could”, “intend”, “expect”, “plan”, “budget”, “forecast”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, “continue”, “evaluating” or similar expressions. Forward-looking statements should not be considered as guarantees of future performance. They are based on our current beliefs, expectations, and assumptions about our business, future plans, projections, anticipated events, and economic conditions. Examples of forward-looking statements include statements about the innovativeness and market position of our products and services, our competitive strengths, and our expectation that the healthy meals replacement joint venture will be competitive. You are advised not to rely on any forward-looking statements. Actual results may differ significantly from historical results or those indicated by the forward-looking statements due to various factors, including but not limited to: risks and uncertainties associated with the Company’s ability to raise additional funding, maintain and grow its business, variability of operating results, maintain and enhance its brand, develop and introduce new products and services, obtain necessary regulatory approvals, successfully integrate acquired companies, technologies, and assets, market and other business development initiatives, industry competition, general government regulations, economic conditions, the impact of the COVID-19 pandemic, dependence on key personnel, ability to attract, hire, and retain qualified personnel, and ability to protect its intellectual property. Shineco encourages you to review other factors that may affect its future results in its filings with the Securities and Exchange Commission. The forward-looking statements in this press release are based on information currently available to us and speak only as of the date of this press release. Shineco assumes no obligation to update any forward-looking statements except as required by applicable rules and regulations.

For more information, please contact:


Mobile: +86-010-68130220

Precept Investor Relations LLC

David J. Rudnick

Mobile: +1-646-694-8538